Literature DB >> 30924680

Utilization of volumetric magnetic resonance imaging for baseline and surveillance imaging in Neuro-oncology.

Samantha J Mills1,2, Mark R Radon1, Richard D Baird2,3, C Oliver Hanemann2,4, Debbie Keatley2, Joanne Lewis2,5, Jonathan Pollock2,6, Paul Sanghera2,7, Thomas Santarius2,8, Gillian Whitfield2,9, Rasheed Zakaria2,10, Jenkinson Michael D2,10.   

Abstract

The acquisition of volumetric post-contrast MRI has clear advantages in the interpretation of neuro-oncology studies but has yet to find its way into routine clinical practice beyond planning scans for surgery and radiotherapy. This commentary briefly highlights the benefits of these techniques whilst dispelling some of the perceived disadvantages.

Mesh：

Year:  2019        PMID： 30924680      PMCID： PMC6592091          DOI： 10.1259/bjr.20190059

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  15 in total

1.  MP RAGE: a three-dimensional, T1-weighted, gradient-echo sequence--initial experience in the brain.

Authors:  M Brant-Zawadzki; G D Gillan; W R Nitz
Journal:  Radiology       Date:  1992-03       Impact factor: 11.105

Review 2.  Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.

Authors:  Benjamin M Ellingson; Martin Bendszus; Jerrold Boxerman; Daniel Barboriak; Bradley J Erickson; Marion Smits; Sarah J Nelson; Elizabeth Gerstner; Brian Alexander; Gregory Goldmacher; Wolfgang Wick; Michael Vogelbaum; Michael Weller; Evanthia Galanis; Jayashree Kalpathy-Cramer; Lalitha Shankar; Paula Jacobs; Whitney B Pope; Dewen Yang; Caroline Chung; Michael V Knopp; Soonme Cha; Martin J van den Bent; Susan Chang; W K Al Yung; Timothy F Cloughesy; Patrick Y Wen; Mark R Gilbert
Journal:  Neuro Oncol       Date:  2015-08-05       Impact factor: 12.300

3.  Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab-a report from the BELOB trial.

Authors:  Renske Gahrmann; Martin van den Bent; Bronno van der Holt; René Michel Vernhout; Walter Taal; Maaike Vos; Jan Cees de Groot; Laurens Victor Beerepoot; Jan Buter; Zwenneke Hendrieke Flach; Monique Hanse; Bas Jasperse; Marion Smits
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

4.  Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient.

Authors:  Gisele Brasil Caseiras; Olga Ciccarelli; Daniel R Altmann; Christopher E Benton; Daniel J Tozer; Paul S Tofts; Tarek A Yousry; Jeremy Rees; Adam D Waldman; Hans Rolf Jäger
Journal:  Radiology       Date:  2009-09-29       Impact factor: 11.105

5.  Reliability of tumor volume estimation from MR images in patients with malignant glioma. Results from the American College of Radiology Imaging Network (ACRIN) 6662 Trial.

Authors:  Birgit B Ertl-Wagner; Jeffrey D Blume; Donald Peck; Jayaram K Udupa; Benjamin Herman; Anthony Levering; Ilona M Schmalfuss
Journal:  Eur Radiol       Date:  2008-10-17       Impact factor: 5.315

6.  Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study.

Authors:  Thomas Bachelot; Gilles Romieu; Mario Campone; Véronique Diéras; Claire Cropet; Florence Dalenc; Marta Jimenez; Emilie Le Rhun; Jean-Yves Pierga; Anthony Gonçalves; Marianne Leheurteur; Julien Domont; Maya Gutierrez; Hervé Curé; Jean-Marc Ferrero; Catherine Labbe-Devilliers
Journal:  Lancet Oncol       Date:  2012-11-02       Impact factor: 41.316

7.  Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation.

Authors:  Jeremy Rees; Hilary Watt; H Rolf Jäger; Chris Benton; Daniel Tozer; Paul Tofts; Adam Waldman
Journal:  Eur J Radiol       Date:  2008-07-15       Impact factor: 3.528

8.  Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas.

Authors:  Tetsuo Hashiba; Naoya Hashimoto; Shuichi Izumoto; Tsuyoshi Suzuki; Naoki Kagawa; Motohiko Maruno; Amami Kato; Toshiki Yoshimine
Journal:  J Neurosurg       Date:  2009-04       Impact factor: 5.115

9.  Recommendations for imaging tumor response in neurofibromatosis clinical trials.

Authors:  Eva Dombi; Simone L Ardern-Holmes; Dusica Babovic-Vuksanovic; Fred G Barker; Steve Connor; D Gareth Evans; Michael J Fisher; Stephane Goutagny; Gordon J Harris; Diego Jaramillo; Matthias A Karajannis; Bruce R Korf; Victor Mautner; Scott R Plotkin; Tina Y Poussaint; Kent Robertson; Chie-Schin Shih; Brigitte C Widemann
Journal:  Neurology       Date:  2013-11-19       Impact factor: 9.910

10.  Increased sensitivity to pathological brain changes using co-registration of magnetic resonance imaging scans.

Authors:  J Burdett; J Stevens; D Flügel; E Williams; J S Duncan; L Lemieux
Journal:  Acta Radiol       Date:  2006-12       Impact factor: 1.990
View more
  1 in total

1.  Three-dimensional U-Net Convolutional Neural Network for Detection and Segmentation of Intracranial Metastases.

Authors:  Jeffrey D Rudie; David A Weiss; John B Colby; Andreas M Rauschecker; Benjamin Laguna; Steve Braunstein; Leo P Sugrue; Christopher P Hess; Javier E Villanueva-Meyer
Journal:  Radiol Artif Intell       Date:  2021-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.